Session 5: Bridging clinic with biology: Emerging drugable pathways on the horizon
Chairs: Giuseppe Curigliano (Italy), Clifford Hudis (USA)
- Targeting CDK 4-6 pathway (Richard S. Finn, USA)
- Targeting DNA repair pathways (Andrew Tutt, United Kingdom)
- Targeting PIK3CA pathway (José Baselga, USA)
- Targeting FGFR pathway (Nicholas Turner, United Kingdom)
- Discussion